Lee E Rubin

Dr. Lee E Rubin

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in JAAOS: Global Research and Reviews
Verified
Journal Article
Open access
MHMonique S. Haynes
Monique S. Haynes
KAKareme D. Alder
Kareme D. Alder
CTCourtney Toombs
Courtney Toombs
IAIkechukwu C. Amakiri
Ikechukwu C. Amakiri
LRLee E Rubin
Lee E Rubin
JGJonathan N Grauer
Jonathan N Grauer
Introduction: Postoperative delirium is common for patients with hip fracture. Predictors of postoperative delirium and its association with preexisting dementia and adverse postoperative outcomes in a geriatric hip fracture population were assessed. Methods: Patients with hip fracture aged 60 years and older were identified in the 2016 and 2017 National Surgical Quality Improvement Program Procedure Targeted Databases. Independent risk factors of postoperative delirium were identified. Associations with mortality, readmission, and revision surgery were evaluated using moderation and mediation analysis. Results: Of 18,754 patients with hip fracture, 30.2% had preoperative dementia, 18.8% had postoperative delirium, and 8.3% had both preoperative dementia and postoperative delirium. Independent predictors of postoperative delirium were as follows: older age, male sex, higher American Society of Anesthesiologists score, dependent functional status, nongeneral anesthesia, preoperative diabetes, bleeding disorder, and preoperative dementia. Preoperative dementia and postoperative delirium each had an independent correlation with 30-day mortality (odds ratios = 2.06 and 1.92, respectively, with P < 0.001 for both). However, when both were present, those with preoperative dementia and postoperative delirium had an even higher odds of mortality based on moderation analysis (odds ratio = 2.25, P < 0.001). Readmissions and reoperations were significantly correlated with postoperative delirium, but not with preoperative dementia. The combination of preoperative dementia and postoperative delirium, however, did have compounding effects. Furthermore, a significant proportion of the total effect of preoperative dementia on mortality and readmission was accounted for by the development of postoperative delirium based on mediation analysis (medeff: 7%, P < 0.001 and medeff: 35%, P < 0.001). Discussion: Postoperative delirium is a potentially preventable postoperative adverse outcome that was seen in 18.8% of 18,754 patients with hip fracture. Those with preoperative dementia seem to be a particularly at-risk subpopulation. Quality improvement initiatives to minimize postoperative delirium in this hip fracture population should be considered and optimized.

14 December 2022 in Arthroplasty Today
Verified
Journal Article
Open access
NPNeil Pathak
Neil Pathak
PBPat Bovonratwet
Pat Bovonratwet
JPJames J. Purtill
James J. Purtill
JBJenna A. Bernstein
Jenna A. Bernstein
MGMarjorie Golden
Marjorie Golden
LRLee E Rubin
Lee E Rubin
Studies analyzing the incidence and clinical implications of postoperative hematomas after total hip arthroplasty (THA) remain limited. The purpose of the present study was to use the National Surgical Quality Improvement Program (NSQIP) dataset to determine rates, risk factors, and subsequent complications of postoperative hematomas requiring reoperation after primary THA. Study population included patients who underwent primary THA (CPT code: 27130) from 2012-2016 recorded in NSQIP. Patients who developed a hematoma requiring reoperation in the 30-day postoperative period were identified. Multivariate regressions were created to identify patient characteristics, operative variables, and subsequent complications that were associated with a postoperative hematoma requiring reoperation. Among the 149,026 patients who underwent primary THA, 180 (0.12%) developed a postoperative hematoma requiring reoperation. Risk factors included body mass index (BMI) ≥ 35 (relative risk [RR]: 1.83, P = .011), American Society of Anesthesiologists (ASA) class ≥3 (RR: 2.11, P < .001), and history of bleeding disorder (RR: 2.71, P < .001). Associated intraoperative characteristics were an operative time ≥100 minutes (RR: 2.03, P < .001) and use of general anesthesia (RR: 1.41, P = .028). Patients developing a hematoma requiring reoperation were at higher risk of subsequent deep wound infection (RR: 21.57, P < .001), sepsis (RR: 4.3, P = .012), and pneumonia (RR: 3.69, P = .023). Surgical evacuation for a postoperative hematoma was performed in about 1 in 833 cases of primary THA. Several nonmodifiable and modifiable risk factors were identified. Given the 21.6 times increased risk of subsequent deep wound infection, select, at-risk patients may benefit from closer monitoring for signs of infection.

1 January 2020 in JBJS Open Access
Verified
Journal Article
Open access
AHAri Samuel Hilibrand
Ari Samuel Hilibrand
LRLee E Rubin
Lee E Rubin
JGJonathan N Grauer
Jonathan N Grauer
Background: Over 1 million joint arthroplasties are performed annually in the United States. Ideally, as devices and surgical techniques improve, the number of revision arthroplasties relative to primary arthroplasties should decrease. To our knowledge, this is the first study to evaluate state-by-state disparities in the ratio of revision to primary knee arthroplasty (unicompartmental and total) and total hip arthroplasty (THA). Methods: The National Inpatient Sample was used to identify patients who had undergone primary or revision knee arthroplasty or primary or revision THA from 2001 to 2011. Demographic characteristics, surgical rates, and revision ratios (the number of revision procedures divided by the number of primary procedures) were determined for the United States as a whole and by state. Results: During the study window, 47 states were sampled. For knee arthroplasty, 1,251,484 patients were identified: 91% underwent primary procedures and 9% underwent revision procedures. Compared with the primary knee arthroplasty cohort, the revision knee arthroplasty cohort had a younger mean age, had more male patients, and had more chronic conditions and longer hospitalizations (p < 0.001 for each). Over the years studied, the mean age of patients who had undergone primary knee arthroplasty decreased 1.8 years (p < 0.0001) and the mean age of those who had undergone revision knee arthroplasties decreased 2.4 years (p < 0.0001). The national revision ratio remained unchanged at around 0.1 (p = 0.8792). However, there was a 2.2-fold variation in revision ratio by state (revision ratio state range, 0.065 to 0.141). For THA, 614,638 patients were identified: 85% underwent primary procedures and 15% underwent revision procedures. Compared with the primary THA cohort, the revision THA cohort had an older mean age, had fewer male patients, and had more chronic conditions and longer hospitalizations (p < 0.001 for each). Over the years studied, the mean age of patients who had undergone primary THA decreased 1.5 years (p = 0.0016), whereas patients who had undergone revision had no significant age trend (p = 1.0000). Unlike for knee arthroplasty, the national THA revision ratio trended downward (0.24 evolved to 0.18, p = 0.0016), and there was a 2.1-fold variation in the revision ratio by state (revision ratio state range, 0.119 to 0.248). Conclusions: This study found significant variability in state-by-state revision ratios. It also found that the national revision ratio stayed relatively steady for knee arthroplasty but was decreasing for THA, and that patients who had undergone revision knee arthroplasty were getting younger, whereas patients who had undergone revision THA were not. These discrepancies suggest divergent histories for primary knee arthroplasty and THA and warrant further detailed evaluation. Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

1 October 2003 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
LRLee E Rubin
Lee E Rubin
PSPhilip Brett Stein
Philip Brett Stein
CDCarla DiScala
Carla DiScala
BGBrian E. Grottkau
Brian E. Grottkau

15 September 2021 in Arthroplasty Today
Verified
Journal Article
Open access
HMHarold G. Moore
Harold G. Moore
CSChristopher A. Schneble
Christopher A. Schneble
JKJoseph B. Kahan
Joseph B. Kahan
GPGregory G. Polkowski
Gregory G. Polkowski
LRLee E Rubin
Lee E Rubin
JGJonathan N Grauer
Jonathan N Grauer
Achondroplasia is the most common skeletal dysplasia, and total joint arthroplasty of the hip and/or knee in this patient population may present unique challenges. All patients undergoing primary total hip or total knee arthroplasty (THA or TKA) for osteoarthritis in the 2010-2019 PearlDiver Mariner administrative database with least 90 days of postoperative follow-up were identified. Those with achondroplasia were matched 1:10 to patients without achondroplasia based on age, sex, and medical comorbidities. Ninety-day adverse events were assessed and compared using multivariate logistic regression. Five-year implant survival was determined and compared with Kaplan-Meier implant survival curves. Significance was set at P < .05. For THA, 150 patients with achondroplasia were matched to 1484 patients without and had significantly higher 90 days odds of surgical site infection (odds ratio [OR] = 3.49, P = .005) and readmission (OR = 2.35, P = .016). For TKA, 285 patients with achondroplasia were matched to 2828 without and had higher odds of aggregated any adverse event (OR = 1.52, P = .006) and transfusion (OR = 2.31, P < .001). Rates of the other studied adverse events were not significant for either set of the analyses. At 5 years, implant survival for those with and without achondroplasia was not different for those undergoing THA (P = .321) or TKA (P = .910). The present study represents the largest cohort of patients with achondroplasia undergoing total joint arthroplasty to date. Although several short-term adverse events had greater odds for those with achondroplasia, 5-year survival was not different for those with or without achondroplasia after THA or TKA, supporting confidence in longer term implant success.

1 October 2019 in Current Opinion in Anaesthesiology
Verified
Journal Article
Closed access
JLJinlei Li
Jinlei Li
LRLee E Rubin
Lee E Rubin
EMEdward Mariano
Edward Mariano
To summarize the safety and feasibility of outpatient total joint arthroplasty (TJA) from the perspectives of short-term complications, long-term functional outcomes, patient satisfaction and financial impact, and to provide evidence-based guidance on how to establish an outpatient TJA programme. TJA has been recently transitioned from an exclusively inpatient procedure for all Medicare and Medicaid patients to an outpatient surgery in properly selected total knee arthroplasty patients. This change may decrease costs while maintaining comparable rates of readmission, adverse events, positive surgical outcomes and patient satisfaction. With a standardized clinical pathway, outpatient TJA can be safe and effective in a subset of patients. Essential components of a successful outpatient TJA programme include proper patient selection, preoperative patient/family education, perioperative multidisciplinary coordination and opioid-sparing analgesia, and early and effective postdischarge planning. More studies are needed to further assess and optimize this new care paradigm.